RxDoctor Payments Data

Victoria Mohn

Nurse Practitioner · Massillon, OHNPI 1578081873

Payments from drug & device makers

$2,512in general payments, 2019–2025

Across 150 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$430
  • AbbVie$396
  • Lilly USA, LLC$193
  • Boehringer Ingelheim$169
  • GSK$125
  • Astellas Pharma US Inc$125
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$2,42797%
  • Education$853%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,512 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$9,089
Medicare patients
65
Services billed
155

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban57$39,578
JardianceEmpagliflozin30$24,096
OzempicSemaglutide18$16,514
Spiriva RespimatTiotropium Bromide21$11,925
LinzessLinaclotide18$9,196
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$8,871
Lisinopril139$1,184
Rosuvastatin Calcium85$954
Albuterol Sulfate HfaAlbuterol Sulfate43$877
Levothyroxine Sodium87$742
Losartan Potassium87$659
Omeprazole52$648
Atorvastatin Calcium82$552
Fluticasone Propionate52$542
Methylprednisolone78$488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$34$39,57857 claims
Boehringer IngelheimJardiance, Spiriva Respimat$169$36,02151 claims
Novo NordiskOzempic$430$16,51418 claims
AbbVieLinzess$396$9,19618 claims
GSKTrelegy Ellipta$125$8,87112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Massillon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →